Tsukuba, Japan

Yuji Awamura



 

Average Co-Inventor Count = 7.3

ph-index = 2

Forward Citations = 19(Granted Patents)


Location History:

  • Tsukuba, JP (2008 - 2011)
  • Tokyo, JP (2012)

Company Filing History:


Years Active: 2008-2012

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yuji Awamura: Innovator in Pharmaceutical Crystallization

Introduction

Yuji Awamura is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel crystal forms that enhance drug production and efficacy. With a total of 3 patents to his name, Awamura's work is recognized for its potential impact on the pharmaceutical industry.

Latest Patents

Awamura's latest patents include innovative crystals of benzoxadiazole derivatives. These crystals, specifically the β-form, γ-form, and α-form, are designed to provide a uniform crystal structure with high reproducibility. They are particularly suitable for mass synthesis in industrial production and exhibit excellent photo-resistance while minimizing hygroscopicity. Another significant patent involves the α-form and β-form crystals of an acetanilide derivative, which are useful as ingredients in diabetes remedies. The α-form crystal demonstrates stability and non-hygroscopic properties, making it suitable for medicinal use.

Career Highlights

Yuji Awamura is currently associated with Astellas Pharma GmbH, where he continues to innovate in the field of pharmaceutical crystallization. His work focuses on creating crystal forms that not only improve the quality of drug substances but also facilitate their mass production.

Collaborations

Awamura collaborates with esteemed colleagues such as Souichirou Kawazoe and Kenichirou Sakamoto. Their combined expertise contributes to the advancement of pharmaceutical technologies and the development of effective drug formulations.

Conclusion

In summary, Yuji Awamura is a pioneering inventor whose work in pharmaceutical crystallization is shaping the future of drug production. His innovative approaches and collaborations are paving the way for advancements in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…